300622 博士眼镜
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入353,2128.29%1,360,3831,202,8161,175,865962,237
减:营业总成本306,2466.24%1,186,1441,071,9841,016,777880,745
    其中:营业成本148,2178.41%536,413460,536434,227367,214
               财务费用2,75858.95%8,1967,9194,7219,518
               资产减值损失(1,469)4.83%(15,881)(21,226)(9,999)(4,440)
公允价值变动收益5,092250.70%24,3902,2094,579(832)
投资收益1,044-37.12%8,03010,6168,9246,852
    其中:对联营企业和合营企业的投资收益1--4------
营业利润51,90932.26%193,527130,071166,73190,943
利润总额51,91732.64%191,988129,116164,12592,839
减:所得税费用10,46930.58%38,29827,79932,37018,400
净利润41,44933.17%153,690101,317131,75574,439
减:非控股权益1,54463.17%5,084(2,311)3,690(1,371)
股东净利润39,90532.23%148,606103,628128,06575,810

市场价值指针
每股收益 (元) *0.18038.46%0.6500.4600.7400.450
每股派息 (元) *----0.2700.2700.6000.300
每股净资产 (元) *4.156-7.85%3.9864.3404.5303.947
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容